Circulating vitamin D metabolites and kidney disease in type 1 diabetes
de Boer, I. H. et al. Circulating vitamin D metabolites and kidney disease in type 1 diabetes. J. Clin. Endocrinol. Metab. http://dx.doi.org/10. 1210/jc.2012-2852.
Vitamin D levels, microvascular complications, and mortality in type 1 diabetes
Joergensen, C., Hovind, P., Schmedes, A., Parving, H. H. & Rossing, P. Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care 34, 1081-1085 (2011).
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): A randomised controlled trial
de Zeeuw, D. et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376, 1543-1551 (2010).
Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established reninangiotensinaldosterone system inhibition
Kim, M. J. et al. Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established reninangiotensinaldosterone system inhibition. Kidney Int. 80, 851-860 (2011).
Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality
Dobnig, H. et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 168, 1340-1349 (2008).
Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate
Joergensen, C. et al. Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Diabetes Care 35, 168-172 (2012).